These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 33898482)

  • 1. Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity.
    Ávila A; Gavela E; Sancho A
    Front Med (Lausanne); 2021; 8():642864. PubMed ID: 33898482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo thrombotic microangiopathy after kidney transplantation.
    Garg N; Rennke HG; Pavlakis M; Zandi-Nejad K
    Transplant Rev (Orlando); 2018 Jan; 32(1):58-68. PubMed ID: 29157988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
    Chandran S; Baxter-Lowe L; Olson JL; Tomlanovich SJ; Webber A
    Transplant Proc; 2011 Jun; 43(5):2097-101. PubMed ID: 21693335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Eculizumab Use in Renal Transplant Recipients.
    Norville K; Stephen J; Mead-Harvey C; Corey R; Votruba C
    Prog Transplant; 2023 Jun; 33(2):162-167. PubMed ID: 36940100
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
    J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo thrombotic microangiopathy in two kidney transplant recipients from the same deceased donor: A case series.
    Roberts D; Siegman I; Andeen N; Woodland D; Deloughery T; Rueda J; Olyaei A; Rehman S; Norman D; Lockridge J
    Clin Transplant; 2020 Jul; 34(7):e13885. PubMed ID: 32314417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and management of thrombotic microangiopathy in kidney transplantation.
    Cho W; Jo SK; Jung CW; Kim MG
    Korean J Transplant; 2023 Mar; 37(1):11-18. PubMed ID: 37064766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
    Andries G; Karass M; Yandrapalli S; Linder K; Liu D; Nelson J; Pawar R; Chugh S
    Exp Hematol Oncol; 2017; 6():4. PubMed ID: 28101432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
    Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
    Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab].
    Latzke AB; Fernández P; Chiurchiu C; Sarmantano D; De Arteaga J; Douthat W; De la Fuente J
    Medicina (B Aires); 2018; 78(2):119-122. PubMed ID: 29659362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
    Okumi M; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():9-13. PubMed ID: 26988663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
    Legendre CM; Licht C; Muus P; Greenbaum LA; Babu S; Bedrosian C; Bingham C; Cohen DJ; Delmas Y; Douglas K; Eitner F; Feldkamp T; Fouque D; Furman RR; Gaber O; Herthelius M; Hourmant M; Karpman D; Lebranchu Y; Mariat C; Menne J; Moulin B; Nürnberger J; Ogawa M; Remuzzi G; Richard T; Sberro-Soussan R; Severino B; Sheerin NS; Trivelli A; Zimmerhackl LB; Goodship T; Loirat C
    N Engl J Med; 2013 Jun; 368(23):2169-81. PubMed ID: 23738544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMA in Kidney Transplantation.
    Imanifard Z; Liguori L; Remuzzi G
    Transplantation; 2023 Nov; 107(11):2329-2340. PubMed ID: 36944606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
    Yamamoto T; Watarai Y; Futamura K; Okada M; Tsujita M; Hiramitsu T; Goto N; Narumi S; Takeda A; Kobayashi T
    Transplant Proc; 2017; 49(1):159-162. PubMed ID: 28104125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated by thrombotic microangiopathy with posterior reversible encephalopathy syndrome successfully treated with eculizumab: A case report.
    Kitamura F; Yamaguchi M; Nishimura M; Katsuno T; Ito M; Sugiyama H; Iwagaitsu S; Nobata H; Kinashi H; Ishimoto T; Banno S; Ito Y
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):254-259. PubMed ID: 35425980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Novo and Recurrent Thrombotic Microangiopathy After Renal Transplantation: Current Concepts in Management.
    Abbas F; Abbas SF
    Exp Clin Transplant; 2022 Jun; 20(6):549-557. PubMed ID: 34546154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors.
    Patel A; Knorr JP; Campos S; Khanmoradi K; Zaki RF; Bradauskaite G
    Exp Clin Transplant; 2016 Apr; 14(2):230-4. PubMed ID: 26030297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab.
    Raufi AG; Scott S; Darwish O; Harley K; Kahlon K; Desai S; Lu Y; Tran MH
    Hematol Rep; 2016 Sep; 8(3):6625. PubMed ID: 27781079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab.
    Iqbal Z; Wood K; Carter V; Goodship TH; Brown AL; Sheerin NS
    Transplant Proc; 2015 Sep; 47(7):2258-61. PubMed ID: 26361694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.